Farrerol (FA) is a traditional Chinese herbal medicine known for its anti-inflammatory and anti-oxidative properties in various diseases. Ferroptosis is an iron-dependent oxidative stress-induced cell death. It is characterized by lipid peroxidation and glutathione depletion and is involved in neuronal injury. However, the role of FA in inhibiting ferroptosis in hypoxic-ischemic encephalopathy (HIE) and its underlying mechanisms are not yet completely elucidated. This study aimed to investigate whether FA could mediate ferroptosis and explore its function and molecular mechanism in HIE. A neonatal rat model of HIE was used, and rats were treated with FA, ML385 (a specific inhibitor of nuclear factor erythroid 2-related factor 2 [Nrf2]), or a combination of both. Neurological deficits, infarction volume, brain water content, pathological changes, and iron ion accumulation in the brain tissues were measured using the Zea-Longa scoring system and triphenyl tetrazolium chloride (TTC), hematoxylin-eosin (HE), and Perls' staining. The expression levels of GSH-Px, MDA, SOD, and ROS in brain tissues were also evaluated. Western blot analysis was performed to analyze the expression of the Nrf2 pathway and ferroptosis-related proteins. The results showed that FA administration significantly reduced neuronal damage, infarct volume, cerebral edema, and iron ion accumulation and inhibited MDA and ROS levels while promoting GSH-Px and SOD levels. FA also increased the expression levels of glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), Nrf2, and HO-1. Moreover, the combination of ML385 and FA in HIE abolished the FA protective effects. Therefore, the study concludes that FA exerts a neuroprotective effect after HIE by inhibiting oxidative stress and ferroptosis via the Nrf2 signaling pathway.

Department of Science and education Pu'er People's Hospital Yunnan People's Republic of China

Zobrazit více v PubMed

Zhao M, Zhu P, Fujino M, Zhuang J, Guo H, Sheikh I, Zhao L, Li XK. Oxidative stress in hypoxic-ischemic encephalopathy: molecular mechanisms and therapeutic strategies. Int J Mol Sci. 2016:17. doi: 10.3390/ijms17122078. PubMed DOI PMC

Greco P, Nencini G, Piva I, Scioscia M, Volta CA, Spadaro S, Neri M, Bonaccorsi G, Greco F, Cocco I, Sorrentino F, D’Antonio F, Nappi L. Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg. 2020;120:277–288. doi: 10.1007/s13760-020-01308-3. PubMed DOI

Frajewicki A, Lastuvka Z, Borbelyova V, Khan S, Jandova K, Janisova K, Otahal J, Myslivecek J, Riljak V. Perinatal hypoxic-ischemic damage: review of the current treatment possibilities. Physiol Res. 2020;69:S379–S401. doi: 10.33549/physiolres.934595. PubMed DOI PMC

Yu S, Doycheva DM, Gamdzyk M, Gao Y, Guo Y, Travis ZD, Tang J, Chen WX, Zhang JH. BMS-470539 attenuates oxidative stress and neuronal apoptosis via MC1R/cAMP/PKA/Nurr1 signaling pathway in a neonatal hypoxic-ischemic rat model. Oxid Med Cell Longev. 2022;2022:4054938. doi: 10.1155/2022/4054938. PubMed DOI PMC

Peeples ES, Genaro-Mattos TC. Ferroptosis: A Promising therapeutic target for neonatal hypoxic-ischemic brain injury. Int J Mol Sci. 2022;23:7420. doi: 10.3390/ijms23137420. PubMed DOI PMC

Zhu K, Zhu X, Liu S, Yu J, Wu S, Hei M. Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting ferroptosis and neuroinflammation in neonatal rats via the HMGB1/GPX4 pathway. Oxid Med Cell Longev. 2022;2022:8438528. doi: 10.1155/2022/8438528. PubMed DOI PMC

Lin W, Zhang T, Zheng J, Zhou Y, Lin Z, Fu X. Ferroptosis is involved in hypoxic-ischemic brain damage in neonatal rats. Neuroscience. 2022;487:131–142. doi: 10.1016/j.neuroscience.2022.02.013. PubMed DOI

Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401–2421. doi: 10.1016/j.cell.2022.06.003. PubMed DOI PMC

Kuang G, Wang W, Xiong D, Zeng C. An NADPH sensor that regulates cell ferroptosis. J Transl Med. 2022;20:474. doi: 10.1186/s12967-022-03658-3. PubMed DOI PMC

Zeng C, Tang H, Chen H, Li M, Xiong D. Ferroptosis: a new approach for immunotherapy. Cell Death Discov. 2020;6:122. doi: 10.1038/s41420-020-00355-2. PubMed DOI PMC

Zeng C, Lin J, Zhang K, Ou H, Shen K, Liu Q, Wei Z, Dong X, Zeng X, Zeng L, Wang W, Yao J. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling. Cancer Sci. 2022;113:3766–3775. doi: 10.1111/cas.15531. PubMed DOI PMC

Wang X, Wang Y, Huang D, Shi S, Pei C, Wu Y, Shen Z, Wang F, Wang Z. Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. Int Immunopharmacol. 2022;112:109186. doi: 10.1016/j.intimp.2022.109186. PubMed DOI

Li X, Chen J, Yuan S, Zhuang X, Qiao T. Activation of the P62-Keap1-NRF2 pathway protects against ferroptosis in radiation-induced lung injury. Oxid Med Cell Longev. 2022;2022:8973509. doi: 10.1155/2022/8973509. PubMed DOI PMC

Chae J, Kim JS, Choi ST, Lee SG, Ojulari OV, Kang YJ, Kwon TK, Nam JO. Farrerol induces cancer cell death via erk activation in SKOV3 cells and attenuates TNF-alpha-mediated lipolysis. Int J Mol Sci. 2021;22:9400. doi: 10.3390/ijms22179400. PubMed DOI PMC

Yan C, Zhang X, Miao J, Yuan H, Liu E, Liang T, Li Q. Farrerol directly targets GSK-3beta to activate Nrf2-ARE pathway and protect EA.hy926 cells against oxidative stress-induced injuries. Oxid Med Cell Longev. 2020;2020:5967434. doi: 10.1155/2020/5967434. PubMed DOI PMC

Qin X, Xu X, Hou X, Liang R, Chen L, Hao Y, Gao A, Du X, Zhao L, Shi Y, Li Q. The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review. Pharm Biol. 2022;60:9–16. doi: 10.1080/13880209.2021.2006723. PubMed DOI PMC

Ma N, Wei Z, Hu J, Gu W, Ci X. Farrerol ameliorated cisplatin-induced chronic kidney disease through mitophagy induction via Nrf2/PINK1 pathway. Front Pharmacol. 2021;12:768700. doi: 10.3389/fphar.2021.768700. PubMed DOI PMC

Zhou L, Yang S, Zou X. Farrerol alleviates myocardial ischemia/reperfusion injury by targeting macrophages and NLRP3. Front Pharmacol. 2022;13:879232. doi: 10.3389/fphar.2022.879232. PubMed DOI PMC

Wang L, Wei W, Xiao Q, Yang H, Ci X. Farrerol ameliorates APAP-induced hepatotoxicity via activation of Nrf2 and autophagy. Int J Biol Sci. 2019;15:788–799. doi: 10.7150/ijbs.30677. PubMed DOI PMC

Cui B, Zhang S, Wang Y, Guo Y. Farrerol attenuates beta-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line. Biomed Pharmacother. 2019;109:112–119. doi: 10.1016/j.biopha.2018.10.053. PubMed DOI

Li Y, Zeng Y, Meng T, Gao X, Huang B, He D, Ran X, Du J, Zhang Y, Fu S, Hu G. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson’s disease by suppressing the activation of the AKT and NF-kappaB signaling pathways. Int Immunopharmacol. 2019;75:105739. doi: 10.1016/j.intimp.2019.105739. PubMed DOI

Cui B, Guo X, You Y, Fu R. Farrerol attenuates MPP(+) -induced inflammatory response by TLR4 signaling in a microglia cell line. Phytother Res. 2019;33:1134–1141. doi: 10.1002/ptr.6307. PubMed DOI

Zhou Y, Wang S, Zhao J, Fang P. Asiaticoside attenuates neonatal hypoxic-ischemic brain damage through inhibiting TLR4/NF-kappaB/STAT3 pathway. Ann Transl Med. 2020;8:641. doi: 10.21037/atm-20-3323. PubMed DOI PMC

Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91. doi: 10.1161/01.STR.20.1.84. PubMed DOI

Niu RZ, Xiong LL, Zhou HL, Xue LL, Xia QJ, Ma Z, Jin Y, Chen L, Jiang Y, Wang TH, Liu J. Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway. Chin Med. 2021;16:105. doi: 10.1186/s13020-021-00517-z. PubMed DOI PMC

Song S, Han Y, Zhang Y, Ma H, Zhang L, Huo J, Wang P, Liang M, Gao M. Protective role of citric acid against oxidative stress induced by heavy metals in Caenorhabditis elegans. Environ Sci Pollut Res Int. 2019;26:36820–36831. doi: 10.1007/s11356-019-06853-w. PubMed DOI

Zeng C, Shao Z, Wei Z, Yao J, Wang W, Yin L, YangOu H, Xiong D. The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation. Cell Mol Biol Lett. 2021;26:7. doi: 10.1186/s11658-021-00249-w. PubMed DOI PMC

Zhu K, Zhu X, Sun S, Yang W, Liu S, Tang Z, Zhang R, Li J, Shen T, Hei M. Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats. Exp Neurol. 2021;345:113828. doi: 10.1016/j.expneurol.2021.113828. PubMed DOI

Xiong Q, Li X, Xia L, Yao Z, Shi X, Dong Z. Dihydroartemisinin attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting oxidative stress. Mol Brain. 2022;15:36. doi: 10.1186/s13041-022-00921-. PubMed DOI PMC

Elias-Miro M, Jimenez-Castro MB, Rodes J, Peralta C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res. 2013;47:555–568. doi: 10.3109/10715762.2013.811721. PubMed DOI

Ma N, Wei W, Fan X, Ci X. Farrerol attenuates cisplatin-induced nephrotoxicity by inhibiting the reactive oxygen species-mediated oxidation, inflammation, and apoptotic signaling pathways. Front Physiol. 2019;10:1419. doi: 10.3389/fphys.2019.01419. PubMed DOI PMC

Zhang X, Ding M, Zhu P, Huang H, Zhuang Q, Shen J, Cai Y, Zhao M, He Q. New insights into the Nrf-2/HO-1 signaling axis and its application in pediatric respiratory diseases. Oxid Med Cell Longev. 2019;2019:3214196. doi: 10.1155/2019/3214196. PubMed DOI PMC

Wu Y, Qian J, Li K, Li W, Yin W, Jiang H. Farrerol alleviates collagenase-induced tendinopathy by inhibiting ferroptosis in rats. J Cell Mol Med. 2022;26:3483–3494. doi: 10.1111/jcmm.17388. PubMed DOI PMC

Ma H, Wang X, Zhang W, Li H, Zhao W, Sun J, Yang M. Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis. Oxid Med Cell Longev. 2020;2020:9067610. doi: 10.1155/2020/9067610. PubMed DOI PMC

Fu C, Wu Y, Liu S, Luo C, Lu Y, Liu M, Wang L, Zhang Y, Liu X. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 2022;289:115021. doi: 10.1016/j.jep.2022.115021. PubMed DOI

Serum Glutathione and Malondialdehyde Levels as Predictors of Early Neurological Deficits and Short-Term Outcomes in Acute Cerebral Infarction